Carl Marshall Reeves and logo

Reeves Foundation: Macular Degeneration Research Grant

Carl Marshall Reeves and

Funding Amount

US $2,500 - US $125,000

Deadline

Deadline not published

Grant Type

Foundation

Can we apply?

Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.

Eligible organizations

  • Normally we focus on research facilities of various universities and medical centers throughout the United States.

Required status

  • 501(c)(3) tax-exempt status

Other requirements

  • More than one request can be received from the same organization.
  • However, please realize that each year our budget of grants to be awarded and number of requests vary.
  • So please keep in mind that you are in essence “competing” against yourself.
  • If you have multiple requests, providing us a priority of those items would be appreciated.

Not eligible / not funded

  • Not eligible: The monies awarded may not be used for any overhead, indirect administrative costs, or endowment funds.
  • Not eligible: Normal operational items
  • Not eligible: Supplies
  • Not eligible: Consumables
  • Not eligible: Salaries
  • Not eligible: Administrative
  • Not eligible: Overhead items
  • Not eligible: Multiyear requests
  • Not eligible: Exceptions would be for a building or a long term project.

Overview

Funder: Carl Marshall Reeves and Mildred Almen Reeves Foundation Grant

The Reeves Foundation supports research aimed at understanding and treating macular degeneration, a condition that has personally affected the founder's family. Established in 1997, the foundation allocates 50% of its grants to research and the other half to local charities in Columbus, Indiana. Nonprofit organizations exempt under IRS code 501(c)(3) are eligible to apply, but funds cannot be used for administrative costs. The foundation prioritizes equipment purchases and partnerships with other funding sources.

Background
The Carl Marshall and Mildred Almen Reeves Foundation was formed in 1997 by Mrs. Mildred Reeves in honor of her late husband, Carl Reeves. Mrs. Reeves' life explains the Foundation's purpose. Mrs. Reeves was a very generous woman who enthusiastically supported local community organizations. Mrs. Reeves was particularly interested in education, history, and the arts. Both Mrs. Reeves and her brother had macular degeneration of the eye. In her later years, Mrs. Reeves' lifestyle was dramatically affected by her condition; she passed away in 1999 at the age of 96.
Purpose of the Foundation
50% of grants to be used for macular degeneration of the eye research50% of grants to be used for local organized charities in the Columbus, Indiana area
Overhead Policy Statement
The policy of the Foundation is to fund projects themselves or capital expenditures. The monies awarded may not be used for any overhead, indirect administrative costs, or endowment funds.

Eligibility

Nonprofit charitable organizations that are exempt from federal taxes under section 501(c) (3) of the IRS Revenue Code can apply for grant.Normally we focus on research facilities of various universities and medical centers throughout the United States.More than one request can be received from the same organization.
However, please realize that each year our budget of grants to be awarded and number of requests vary. So please keep in mind that you are in essence “competing” against yourself. If you have multiple requests, providing us a priority of those items would be appreciated.Similarly, your organization can apply for a grant each year and receive awards in multiple years.

Ineligibility

The monies awarded may not be used for any overhead, indirect administrative costs, or endowment funds.Generally, the foundation does not fund normal operational items, supplies, consumables, salaries, administrative or overhead items.Normally, we do not fund multiyear requests.Exceptions would be for a building or a long term project.

Past recipients of this program

Recent awards under this program (from Carl Marshall Reeves and's IRS filings)

  • Umass Memorial Foundation (U Mass Medical School)

    Shrewsbury, MA · 2025

    $85K

  • Vumc (Vanderbilt Eye Institute)

    Nashville, TN · 2025

    $50K

  • $45K

  • Washington University in St Louis

    St Louis, MO · 2025

    $40K

  • Indiana University

    Indianapolis, IN · 2025

    $30K

32 grants in Carl Marshall Reeves and's 2020–2025 filings reference “Macular Degeneration Research Grant” in their stated purpose. Amounts and places as reported by the funder.

What Carl Marshall Reeves actually gave

Source: IRS Form 990-PF, 2025

Grants in 2025
30
Total given
$617K
Median grant
$15K
Range
$1,499–$85K
  • By dollars: Indiana 49%, Massachusetts 14%, Tennessee 8%. Top recipient cities: Columbus, IN; Indianapolis, IN; Shrewsbury, MA.
  • 0% of grants with a stated purpose were for general or operating support.
  • 13% of recipients were new grantees, not repeat recipients.

Example grants

  • Umass Memorial Foundation (U Mass Medical School) · Shrewsbury, MA

    Macular degeneration research of the eye studies

    $85K

  • Family Service Inc · Columbus, IN

    Clinical service counseling program

    $54K

  • Vumc (Vanderbilt Eye Institute) · Nashville, TN

    Macular degeneration research of the eye studies

    $50K

  • University of Wisconsin · Madison, WI

    Macular degneration research of the eye studies

    $45K

  • Retina Foundation of the Southwest · Dallas, TX

    Macular degeneration rsearch of the eye studies

    $45K

IRS Form 990-PF, 2025. Amounts as reported by the funder. Full 990 history →

Focus Areas & Funding Uses

Fields of Work

  • Nonprofits
  • Science research
  • Hearing and vision

Categories

Browse similar grants by category

Related Grants

Open grants from this funder and similar programs

Your AI grants department

Ready to apply for Reeves Foundation: Macular Degeneration Research Grant?

Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.

You found Reeves Foundation: Macular Degeneration Research Grant. Now let's win it.

Start writing